CK-7 negative primary lung adenocarcinoma

Cytokeratin (CK) 7 is normally expressed in the vast majority of lung adenocarcinoma (ADC). However, on rare occasions, as reported in this paper, CK7 negativity can challenge the diagnosis of pulmonary ADC. Hence, the need to use a combination of ‘immunomarkers’ such as thyroid transcription factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Tchienga, Dimitri, Ascio, Noelani-Mei, Qureshi, Abid, Razia, Sultana, Romulo, Genato, Asarian, Armand, Xiao, Philip, Nouthe, Brice, Belinga, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10271213/
https://www.ncbi.nlm.nih.gov/pubmed/37332662
http://dx.doi.org/10.1093/jscr/rjad316
_version_ 1785059390752030720
author Tchienga, Dimitri
Ascio, Noelani-Mei
Qureshi, Abid
Razia, Sultana
Romulo, Genato
Asarian, Armand
Xiao, Philip
Nouthe, Brice
Belinga, Dominique
author_facet Tchienga, Dimitri
Ascio, Noelani-Mei
Qureshi, Abid
Razia, Sultana
Romulo, Genato
Asarian, Armand
Xiao, Philip
Nouthe, Brice
Belinga, Dominique
author_sort Tchienga, Dimitri
collection PubMed
description Cytokeratin (CK) 7 is normally expressed in the vast majority of lung adenocarcinoma (ADC). However, on rare occasions, as reported in this paper, CK7 negativity can challenge the diagnosis of pulmonary ADC. Hence, the need to use a combination of ‘immunomarkers’ such as thyroid transcription factor 1, Napsin A, p40, p63 and CK20.
format Online
Article
Text
id pubmed-10271213
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102712132023-06-17 CK-7 negative primary lung adenocarcinoma Tchienga, Dimitri Ascio, Noelani-Mei Qureshi, Abid Razia, Sultana Romulo, Genato Asarian, Armand Xiao, Philip Nouthe, Brice Belinga, Dominique J Surg Case Rep Case Report Cytokeratin (CK) 7 is normally expressed in the vast majority of lung adenocarcinoma (ADC). However, on rare occasions, as reported in this paper, CK7 negativity can challenge the diagnosis of pulmonary ADC. Hence, the need to use a combination of ‘immunomarkers’ such as thyroid transcription factor 1, Napsin A, p40, p63 and CK20. Oxford University Press 2023-06-15 /pmc/articles/PMC10271213/ /pubmed/37332662 http://dx.doi.org/10.1093/jscr/rjad316 Text en Published by Oxford University Press and JSCR Publishing Ltd. © The Author(s) 2023. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Tchienga, Dimitri
Ascio, Noelani-Mei
Qureshi, Abid
Razia, Sultana
Romulo, Genato
Asarian, Armand
Xiao, Philip
Nouthe, Brice
Belinga, Dominique
CK-7 negative primary lung adenocarcinoma
title CK-7 negative primary lung adenocarcinoma
title_full CK-7 negative primary lung adenocarcinoma
title_fullStr CK-7 negative primary lung adenocarcinoma
title_full_unstemmed CK-7 negative primary lung adenocarcinoma
title_short CK-7 negative primary lung adenocarcinoma
title_sort ck-7 negative primary lung adenocarcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10271213/
https://www.ncbi.nlm.nih.gov/pubmed/37332662
http://dx.doi.org/10.1093/jscr/rjad316
work_keys_str_mv AT tchiengadimitri ck7negativeprimarylungadenocarcinoma
AT ascionoelanimei ck7negativeprimarylungadenocarcinoma
AT qureshiabid ck7negativeprimarylungadenocarcinoma
AT raziasultana ck7negativeprimarylungadenocarcinoma
AT romulogenato ck7negativeprimarylungadenocarcinoma
AT asarianarmand ck7negativeprimarylungadenocarcinoma
AT xiaophilip ck7negativeprimarylungadenocarcinoma
AT nouthebrice ck7negativeprimarylungadenocarcinoma
AT belingadominique ck7negativeprimarylungadenocarcinoma

Ejemplares similares